CLX-MET-102

N/A

Report date: 2023/05/22 10:20:11

Base Information

Drug NameCLX-MET-102

Drug Alias NameCLX-MET-102

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGluconeogenesis inhibitorsAMP-activated protein kinases activators

TargetsAMP-activated protein kinases

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellix Bio Pvt Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

ATC CodeN/A